Clinical Report: 2025 Vascular Research Initiatives Conference Highlights

Overview

The 2025 Vascular Research Initiatives Conference (VRIC) convened vascular surgeons, researchers, and clinicians to discuss advances in vascular biology with a focus on multi-omics approaches to identify new therapeutic targets. The event emphasized translational research and multidisciplinary patient management strategies.

Background

VRIC is an annual conference dedicated to the exchange of basic and translational vascular science, fostering collaboration among vascular surgeons, biologists, and trainees. In 2025, VRIC was held in conjunction with the American Heart Association's Vascular Discovery Scientific Sessions to facilitate broader scientific engagement. The conference aims to enhance research techniques, clinical trials, and the application of current standards of care in vascular patient management. It maintains strict adherence to evidence-based practices and does not promote unscientific or unsafe therapies.

Data Highlights

Key Findings

• The 2025 VRIC theme focused on deploying multi-omics technologies to uncover novel therapeutic targets in vascular biology.
• Distinguished lectures highlighted translational vascular surgery research and systems approaches to inflammatory vascular diseases.
• VRIC provided continuing medical education credits, emphasizing evidence-based clinical practice and multidisciplinary patient management.
• Collaboration with the American Heart Association's Vascular Discovery Sessions enabled cost-effective attendance and broader scientific exchange.
• Support was provided by educational grants from Boston Scientific and Gore, ensuring high-quality content delivery.
• Young surgeons within their first 10 years of practice were eligible for VOYAGE scholarships to support conference participation.

Clinical Implications

Clinicians should consider integrating multi-omics data and systems biology approaches into vascular disease research and patient care to identify innovative therapeutic targets. The conference reinforces the importance of evidence-based, multidisciplinary management strategies in vascular surgery. Participation in such forums can enhance clinical trial design and application of current standards of care.

Conclusion

The 2025 VRIC successfully advanced the dialogue on translational vascular research, emphasizing multi-omics approaches and collaborative care models. It remains a vital platform for fostering innovation and improving outcomes in vascular patient management.

References

1. Society for Vascular Surgery/VRIC 2025 -- Vascular Research Initiatives Conference Overview